This topic is both sensitive and critical—post-vaccine brain bleeds, specifically cerebral venous sinus thrombosis (CVST), which have occurred in some young people following COVID-19 vaccination. This issue is complex and nuanced, much like the broader discussion about vaccine risks and benefits. Too often, we see things in black and white; my aim is to illuminate the gray areas.
A Heartbreaking Case: The Tragedy of a Young Life Lost
Recently, a story surfaced in the media that underscores the urgency of this discussion. It was titled, "Our Daughter Should Not Have Died from the COVID Jab." This was the account of a young woman, only 21 years old, who experienced excruciating headaches three times in the week before she tragically passed away due to a brain hemorrhage in March 2021. The family believes she died from complications related to the AstraZeneca COVID-19 vaccine.
BBC Article (August 23, 2024 - Matthew Hill)
'Our daughter should not have died from Covid jab'
Read here >
Her symptoms began 11 days after receiving her vaccine, a timeframe that aligns with the body's immune response mechanisms, particularly the development of IgG antibodies. She reported severe headaches and sickness, symptoms often dismissed as migraines, despite mentioning her recent vaccination. It’s a common problem—patients often know something is wrong, but their concerns are not always taken seriously.
The Science Behind the Symptoms: What We Know About CVST
Cerebral venous sinus thrombosis, a rare form of stroke, occurs when a blood clot forms in the brain’s venous sinuses, leading to increased pressure and possible brain hemorrhage. The condition is rare, but its link to the AstraZeneca vaccine has been noted, particularly among young women.
Please support my research efforts by subscribing to Vejon Health Substack. Your support allows me to continue bringing you my insights in a timely and effective way.
